Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Ritu Baral's Stock Ratings
TD Cowen Analyst
Ritu Baral is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
10.4%
Smart Score
Overall Average Return Percentile
58th
Number of Ratings
66
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | MIST | Buy Now | Milestone Pharmaceuticals | $2.48 | 223.23% | → $8 | Upgrade | Hold → Buy | Get Alert | |
| 12/11/2025 | INSM | Buy Now | Insmed | $198.44 | 35.55% | $231 → $269 | Maintains | Buy | Get Alert | |
| 12/08/2025 | PRAX | Buy Now | Praxis Precision Medicine | $276.10 | 27.85% | $251 → $353 | Maintains | Buy | Get Alert | |
| 12/05/2025 | VERA | Buy Now | Vera Therapeutics | $49.80 | 46.59% | $60 → $73 | Maintains | Buy | Get Alert | |
| 11/20/2025 | INSM | Buy Now | Insmed | $198.44 | 16.41% | $223 → $231 | Maintains | Buy | Get Alert | |
| 11/06/2025 | PVLA | Buy Now | Palvella Therapeutics | $89.15 | 8.81% | $65 → $97 | Maintains | Buy | Get Alert | |
| 10/29/2025 | RNA | Buy Now | Avidity Biosciences | $71.89 | 2.94% | $78 → $74 | Downgrade | Buy → Hold | Get Alert | |
| 10/02/2025 | INSM | Buy Now | Insmed | $198.44 | -2.74% | $154 → $193 | Maintains | Buy | Get Alert | |
| 09/11/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.91 | 44.9% | $35 → $39 | Maintains | Buy | Get Alert | |
| 08/26/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $561.04 | -1.25% | $390 → $554 | Maintains | Buy | Get Alert | |
| 08/04/2025 | AKRO | Buy Now | Akero Therapeutics | $54.70 | 38.94% | → $76 | Initiates | → Buy | Get Alert | |
| 02/05/2025 | PVLA | Buy Now | Palvella Therapeutics | $89.15 | -50.64% | → $44 | Initiates | → Buy | Get Alert | |
| 11/21/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $10 → $9 | Maintains | Hold | Get Alert | |
| 11/18/2024 | SPRO | Buy Now | Spero Therapeutics | $2.33 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 11/18/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.17 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 10/21/2024 | RNA | Buy Now | Avidity Biosciences | $71.89 | 8.5% | $56 → $78 | Maintains | Buy | Get Alert | |
| 10/21/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -6.76% | $282 → $371 | Maintains | Buy | Get Alert | |
| 08/09/2024 | INSM | Buy Now | Insmed | $198.44 | -50.62% | $75 → $98 | Maintains | Buy | Get Alert | |
| 08/06/2024 | SPRO | Buy Now | Spero Therapeutics | $2.33 | — | — | Upgrade | Hold → Buy | Get Alert | |
| 07/30/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $16 → $10 | Downgrade | Buy → Hold | Get Alert | |
| 07/09/2024 | MORF | Buy Now | Morphic Holding | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 06/25/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -29.12% | $260 → $282 | Maintains | Buy | Get Alert | |
| 05/29/2024 | INSM | Buy Now | Insmed | $198.44 | -66.24% | $45 → $67 | Maintains | Buy | Get Alert | |
| 04/18/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $30 → $16 | Maintains | Buy | Get Alert | |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $561.04 | -30.49% | $349 → $390 | Maintains | Outperform | Get Alert | |
| 02/28/2024 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | $4 → $1.55 | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | — | — | $105 → $28 | Maintains | Outperform | Get Alert | |
| 08/08/2023 | SGMT | Buy Now | Sagimet Biosciences | $5.86 | — | — | Initiates | → Outperform | Get Alert | |
| 03/22/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.32 | 721.02% | $125 → $175 | Maintains | Outperform | Get Alert | |
| 01/11/2023 | ALBO | Buy Now | Albireo Pharma | — | — | $68 → $48 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/21/2022 | INSM | Buy Now | Insmed | $198.44 | -73.29% | $56 → $53 | Maintains | Outperform | Get Alert | |
| 10/18/2022 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | $32 → $9 | Maintains | Outperform | Get Alert | |
| 08/16/2022 | APTX | Buy Now | Aptinyx | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $67 → $68.5 | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/08/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.91 | -21.98% | $32 → $21 | Maintains | Outperform | Get Alert | |
| 05/04/2022 | SPRO | Buy Now | Spero Therapeutics | $2.33 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 04/19/2022 | ANTX | Buy Now | AN2 Therapeutics | $1.17 | — | — | Initiates | → Outperform | Get Alert | |
| 11/23/2021 | SPRB | Buy Now | Spruce Biosciences | $82.82 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/23/2021 | RLYB | Buy Now | Rallybio | $0.75 | — | — | Initiates | → Outperform | Get Alert | |
| 07/20/2021 | GHRS | Buy Now | GH Research | $12.91 | — | — | Initiates | → Outperform | Get Alert | |
| 07/13/2021 | ATAI | Buy Now | ATAI Life Sciences | $4.18 | — | — | Initiates | → Outperform | Get Alert | |
| 07/13/2021 | ATAI | Buy Now | ATAI Life Sciences | $4.18 | — | — | Initiates | → Buy | Get Alert | |
| 06/15/2021 | SAGE | Buy Now | Sage Therapeutics | — | — | $100 → $105 | Maintains | Outperform | Get Alert | |
| 06/08/2021 | VERA | Buy Now | Vera Therapeutics | $49.80 | — | — | Initiates | → Outperform | Get Alert | |
| 03/02/2021 | TERN | Buy Now | Terns Pharma | $44.02 | — | — | Initiates | → Outperform | Get Alert | |
| 11/30/2020 | SAGE | Buy Now | Sage Therapeutics | — | — | $96 → $100 | Maintains | Outperform | Get Alert | |
| 11/03/2020 | SPRB | Buy Now | Spruce Biosciences | $82.82 | -46.87% | → $44 | Initiates | → Outperform | Get Alert | |
| 10/06/2020 | MYOK | Buy Now | MyoKardia | — | — | $145 → $225 | Downgrade | Outperform → Market Perform | Get Alert | |
| 06/30/2020 | ICPT | Buy Now | Intercept Pharma | — | — | $149 → $47 | Downgrade | Outperform → Market Perform | Get Alert | |
| 06/29/2020 | PLRX | Buy Now | Pliant Therapeutics | $1.21 | — | — | Initiates | → Outperform | Get Alert | |
| 11/26/2018 | ORTX | Buy Now | Orchard Therapeutics | — | — | → $27 | Initiates | → Outperform | Get Alert | |
| 08/13/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -63.05% | $157 → $147 | Maintains | Outperform | Get Alert | |
| 07/02/2018 | ASNS | Buy Now | Actelis Networks | $1.58 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/12/2018 | AXON | Buy Now | Axon Enterprise | $550.86 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/11/2017 | ASNS | Buy Now | Actelis Networks | $1.58 | — | — | Initiates | → Outperform | Get Alert | |
| 11/27/2017 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | — | Initiates | → Outperform | Get Alert | |
| 11/27/2017 | SPRO | Buy Now | Spero Therapeutics | $2.33 | — | — | Initiates | → Outperform | Get Alert | |
| 08/16/2017 | ALBO | Buy Now | Albireo Pharma | — | — | — | Initiates | → Outperform | Get Alert | |
| 06/01/2017 | MGEN | Buy Now | Miragen Therapeutics | — | — | — | Initiates | → Outperform | Get Alert | |
| 02/03/2017 | AXON | Buy Now | Axovant Sciences Ltd. Common Shares | $550.86 | — | — | Initiates | → Outperform | Get Alert | |
| 01/09/2017 | TIG | Buy Now | Trean Insurance Group | — | — | — | Initiates | → Outperform | Get Alert | |
| 05/31/2016 | ICPT | Buy Now | Intercept Pharma | — | — | $212 → $215 | Maintains | Outperform | Get Alert | |
| 11/23/2015 | MYOK | Buy Now | MyoKardia | — | — | → $24 | Initiates | → Outperform | Get Alert | |
| 09/08/2015 | GBT | Buy Now | Global Blood Therapeutics | — | — | → $80 | Initiates | → Outperform | Get Alert | |
| 02/27/2015 | ALNY | Buy Now | Alnylam Pharmaceuticals | $397.88 | -62.3% | → $150 | Initiates | → Outperform | Get Alert | |
| 09/05/2014 | ICPT | Buy Now | Intercept Pharma | — | — | → $420 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved